Arrowhead Research Corporation (ARWR) is a publicly traded Healthcare sector company. As of November 17, 2026, ARWR trades at $44.59 with a market cap of $6.75B and a P/E ratio of -27.59. ARWR moved +0.86% today. Year to date, ARWR is -34.77%; over the trailing twelve months it is +7.18%. Its 52-week range spans $9.57 to $95.49. Analyst consensus is strong buy with an average price target of $106.89. Rallies surfaces ARWR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ARWR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $44.59 |
| Market Cap | $6.75B |
| P/E Ratio | -27.59 |
| EPS | $-2.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $95.49 |
| 52-Week Low | $9.57 |
| Volume | 1.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $669.50M |
| Net Income | $-272.13M |
| Gross Margin | 0.00% |
12 analysts cover ARWR: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $106.89.